Document details

Field-deployable viral diagnostics using CRISPR-Cas13


Description

Made available in DSpace on 2018-11-26T16:01:08Z (GMT). No. of bitstreams: 0 Previous issue date: 2018-04-27

HHMI

Broad Institute Chemical Biology and Therapeutics Science Shark Tank

NIH

Defense Advanced Research Projects Agency

Paul and Daisy Soros fellowship

NIH National Institute of Allergy and Infectious Diseases

New York Stem Cell foundation

Allen foundation

Vallee foundation

Tan-Yang Center at MIT

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Mitigating global infectious disease requires diagnostic tools that are sensitive, specific, and rapidly field deployable. In this study, we demonstrate that the Cas13-based SHERLOCK (specific high-sensitivity enzymatic reporter unlocking) platform can detect Zika virus (ZIKV) and dengue virus (DENV) in patient samples at concentrations as low as 1 copy per microliter. We developed HUDSON (heating unextracted diagnostic samples to obliterate nucleases), a protocol that pairs with SHERLOCK for viral detection directly from bodily fluids, enabling instrument-free DENVdetection directly from patient samples in <2 hours. We further demonstrate that SHERLOCK can distinguish the four DENV serotypes, as well as region-specific strains of ZIKV from the 2015-2016 pandemic. Finally, we report the rapid (<1 week) design and testing of instrument-free assays to detect clinically relevant viral single-nucleotide polymorphisms.

Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA

Harvard Univ, Dept Organismal & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA

Harvard Med Sch, Div Med Sci, PhD Program Virol, Boston, MA 02115 USA

Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA

MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA

MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA

MIT, Dept Biol Engn, Cambridge, MA 02139 USA

MIT, Dept Hlth Sci & Technol, Cambridge, MA 02139 USA

MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA

MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA

Florida Gulf Coast Univ, Dept Biol Sci, Ft Myers, FL 33965 USA

Univ Nacl Autonoma Honduras, Inst Invest Microbiol, Ctr Invest Genet, Tegucigalpa, Honduras

Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA

Sao Paulo State Univ, Sch Pharmaceut Sci, Araraquara Lab Publ Hlth, Sao Paulo, Brazil

Fac Med Sao Jose do Rio Preto, Lab Pesquisas Virol, Sao Paulo, Brazil

Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA

Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA

HHMI, Chevy Chase, MD 20815 USA

Sao Paulo State Univ, Sch Pharmaceut Sci, Araraquara Lab Publ Hlth, Sao Paulo, Brazil

NIH: U19AI110818

NIH: F30 NRSA 1F30-CA210382

NIH: AI 100190

NIH: 1R01-HG009761

NIH: 1R01-MH110049

NIH: 1DP1-HL141201

Defense Advanced Research Projects Agency: D18AC00006

NIH National Institute of Allergy and Infectious Diseases: R01AI099210

FAPESP: 13/21719-3

Document Type Journal article
Language English
facebook logo  linkedin logo  twitter logo 
mendeley logo

Related documents

No related documents